Financials
- Market Capitalization 534.33 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.58
売上高対価格比率
-6 934.07
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2869 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.85 USD | -2.34% | +1.04% | +5.60% | +175.94% | 560.60 M USD | ||
| 2873 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.82 USD | +4.60% | +27.27% | +16.67% | -12.50% | 550.23 M USD | ||
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.08 USD | -3.45% | -4.35% | -4.35% | +54.00% | 533.28 M USD | ||
| 2914 | EDIT Editas Medicine, Inc. - Common Stock | 3.30 USD | +3.77% | +10.74% | +26.92% | +24.53% | 506.81 M USD |